The Role of Serotherapy in αβ T-Cell/CD19 B-Cell Depleted Haploidentical HSCT
Michael Allen Pulsipher, MD, University of Utah, presents “Optimal rATG Exposure in Pediatric Patients Receiving TCRab/CD19 Depleted Haplo-HSCT Markedly Decreases Relapse, TRM, and Mortality” at the 2024 International Symposium on αβ T-Cell/CD19 B-Cell Depleted Haploidentical Stem Cell Transplantation.
